Abstract
Objective: Analyze ECV results when propofol is used for sedation.
Design: Longitudinal prospective analysis
Setting: 1st of January of 2018 and
31st of December of 2020.
Population: Pregnant women with non-cephalic presentation and no
contraindication for vaginal delivery.
Methods: Longitudinal prospective analysis of ECV performed in a
tertiary hospital between the Just before the procedure, 0.2 mg/min of
ritodrine was intravenously administered for 30 minutes. Sedation or
neuraxial anesthesia was performed before the ECV.
Main Outcome Measures: ECV success rate, Hypotension during procedure,
ECV complication rate, cesarean section 24 h after ECV.
Results: 242 pregnant women underwent ECV. All data were available for
analysis just in 153 cases. ECV success rate was 66.9%. Sedation was
performed in 88.8% and neuraxial anesthesia was carried out in 11.2%.
For the sedation group, propofol was used in 96.3%. Emergency cesarean
section rate during the following 24 hours of ECV was 6.7%. No
difference in the emergent cesarean section during the 24 hours
following the ECV rate when sedation or neuraxial anesthesia were
performed (p=0.53).
Conclusions: ECV is a safe and effective procedure. Sedation with
propofol is useful for analgesia in ECV.
Funding: The authors received no financial support for the research,
authorship, and/or publication of this article.
Keywords: Sedation, Propofol, ECV, Breech presentation
Tweetable abstract: Propofol does not increase emergent cesarean section
nor clinically relevant hypotension in ECV.